Merck has acquired Resolution Spectra Systems, a company producing Raman spectroscopy instrumentation for bioprocess analytical monitoring. Financial details of the acquisition were not disclosed.
“This acquisition supports our vision of delivering intensified, connected and continuous bioprocessing”, said Andrew Bulpin, head of Process Solutions, Life Science, at Merck. “Raman measurement technology, coupled with the software to analyse and manage the generated data, allows us to offer unique and integrated solutions to help our customers optimise their bioprocesses.”
This acquisition supports Merck’s recently launched Bio4C™ Software Suite, that combines process control, analytics and plant-level automation. Raman technology’s bioprocess monitoring sensors complement the “collect” dimension of the Bio4C™ Software Suite, as it provides real-time process analytics across multiple process parameters via in-line measurement. By combining these Raman technology sensors with the software to manage the data that they provide, Merck is able to offer integrated bioprocessing capabilities.